Stockreport

Valneva Completes Phase 3 Trial Recruitment for its Inactivated COVID-19 Vaccine Candidate

Valneva SE - American Depositary Shares  (VALN) 
PDF Saint-Herblain (France), June 3, 2021 –Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious d [Read more]